Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report
- 1 January 2010
- journal article
- case report
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (43), 5518-22
- https://doi.org/10.3748/wjg.v16.i43.5518
Abstract
A case of hepatocellular carcinoma (HCC) with pulmonary recurrence after liver transplantation for HCC is presented in this report. The patient showed disease progression on sorafenib therapy demonstrated by computed tomography scans as well as serial serum α-fetoprotein (AFP) elevation. After his immunosuppression therapy was successfully transitioned to sirolimus and a continuation of sorafenib, he achieved partial remission based on RECIST criteria and normalization of AFP. Mammalian target of rapamycin inhibitors including sirolimus alone or in conjunction with sorafenib may be useful in the treatment of post transplant HCC.Keywords
This publication has 18 references indexed in Scilit:
- Liver transplantation for hepatocellular carcinoma: the Kyoto experienceJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinomaJournal of Cellular and Molecular Medicine, 2009
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinomaMedical Oncology, 2009
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP‐9Hepatology Research, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Sirolimus Therapy in Liver Transplant Patients: An Initial Experience at a Single CenterTransplantation Proceedings, 2008
- Systemic Therapy for Hepatocellular CarcinomaThe Cancer Journal, 2008
- Epidemiology of Hepatocellular Carcinoma in Hispanics in the United StatesArchives of Internal Medicine, 2007
- Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver TransplantationTransplantation, 2007
- Targeted Agents for the Treatment of Advanced Renal Cell CarcinomaCurrent Drug Targets, 2005